> top > docs > PMC:7094941 > annotations

PMC:7094941 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T1 637-641 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T2 859-871 Body_part denotes eosinophilic http://purl.org/sig/ont/fma/fma62861
T3 1214-1221 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T4 3555-3559 Body_part denotes lung http://purl.org/sig/ont/fma/fma7195
T5 3585-3592 Body_part denotes genomes http://purl.org/sig/ont/fma/fma84116
T6 3659-3669 Body_part denotes nucleotide http://purl.org/sig/ont/fma/fma82740
T7 4026-4038 Body_part denotes eosinophilic http://purl.org/sig/ont/fma/fma62861
T8 4202-4209 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T9 6272-6277 Body_part denotes Serum http://purl.org/sig/ont/fma/fma63083
T10 6375-6382 Body_part denotes Protein http://purl.org/sig/ont/fma/fma67257
T11 6532-6539 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T12 6630-6635 Body_part denotes Blood http://purl.org/sig/ont/fma/fma9670
T13 6686-6693 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T14 6739-6746 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T15 6853-6856 Body_part denotes DNA http://purl.org/sig/ont/fma/fma74412
T16 6932-6936 Body_part denotes mRNA http://purl.org/sig/ont/fma/fma67122
T17 6965-6969 Body_part denotes mRNA http://purl.org/sig/ont/fma/fma67122
T18 7371-7375 Body_part denotes cell http://purl.org/sig/ont/fma/fma68646
T19 7524-7532 Body_part denotes proteins http://purl.org/sig/ont/fma/fma67257
T20 8247-8254 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T21 8446-8454 Body_part denotes proteins http://purl.org/sig/ont/fma/fma67257
T22 8491-8504 Body_part denotes immune system http://purl.org/sig/ont/fma/fma9825
T23 8629-8636 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T24 8745-8752 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T25 8831-8839 Body_part denotes proteins http://purl.org/sig/ont/fma/fma67257
T26 8887-8899 Body_part denotes eosinophilic http://purl.org/sig/ont/fma/fma62861
T27 9093-9098 Body_part denotes Blood http://purl.org/sig/ont/fma/fma9670
T28 9220-9227 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T29 9540-9550 Body_part denotes amino acid http://purl.org/sig/ont/fma/fma82739
T30 9636-9643 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257
T31 9823-9826 Body_part denotes DNA http://purl.org/sig/ont/fma/fma74412
T32 9906-9909 Body_part denotes RNA http://purl.org/sig/ont/fma/fma67095
T33 9960-9963 Body_part denotes DNA http://purl.org/sig/ont/fma/fma74412
T34 10456-10463 Body_part denotes protein http://purl.org/sig/ont/fma/fma67257

LitCovid-PD-UBERON

Id Subject Object Predicate Lexical cue uberon_id
T1 3555-3559 Body_part denotes lung http://purl.obolibrary.org/obo/UBERON_0002048
T2 6272-6277 Body_part denotes Serum http://purl.obolibrary.org/obo/UBERON_0001977
T3 6630-6635 Body_part denotes Blood http://purl.obolibrary.org/obo/UBERON_0000178
T4 8491-8504 Body_part denotes immune system http://purl.obolibrary.org/obo/UBERON_0002405
T5 9093-9098 Body_part denotes Blood http://purl.obolibrary.org/obo/UBERON_0000178

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T1 4-12 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T2 4-8 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T3 192-200 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T4 192-196 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T5 248-256 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T6 315-348 Disease denotes severe acute respiratory syndrome http://purl.obolibrary.org/obo/MONDO_0005091
T7 362-370 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T8 362-366 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T9 510-518 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T10 543-551 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T11 543-547 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T12 556-564 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T13 556-560 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T14 691-699 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T15 691-695 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T16 734-742 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T17 902-910 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T18 1638-1647 Disease denotes pneumonia http://purl.obolibrary.org/obo/MONDO_0005249
T19 2049-2057 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T20 2049-2053 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T21 2087-2095 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T22 2100-2124 Disease denotes coronavirus disease 2019 http://purl.obolibrary.org/obo/MONDO_0100096
T23 2160-2193 Disease denotes severe acute respiratory syndrome http://purl.obolibrary.org/obo/MONDO_0005091
T24 2195-2199 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T25 2219-2227 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T26 2418-2426 Disease denotes diabetes http://purl.obolibrary.org/obo/MONDO_0005015
T27 2431-2443 Disease denotes hypertension http://purl.obolibrary.org/obo/MONDO_0005044
T28 2459-2467 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T29 2459-2463 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T30 2699-2707 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T31 2699-2703 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T32 2881-2896 Disease denotes viral infection http://purl.obolibrary.org/obo/MONDO_0005108
T33 2887-2896 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550
T34 3297-3305 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T35 3342-3346 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T36 3360-3368 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T37 3360-3364 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T38 3621-3629 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T39 3621-3625 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T40 3683-3687 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T41 3804-3812 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T42 3804-3808 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T43 3873-3877 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T44 3932-3936 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T45 4122-4132 Disease denotes infections http://purl.obolibrary.org/obo/MONDO_0005550
T46 4612-4620 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T47 4766-4774 Disease denotes diabetes http://purl.obolibrary.org/obo/MONDO_0005015
T48 4778-4790 Disease denotes hypertension http://purl.obolibrary.org/obo/MONDO_0005044
T49 4843-4851 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T50 4843-4847 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T51 4855-4863 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T52 4855-4859 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T53 4963-4971 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T54 5115-5123 Disease denotes diabetes http://purl.obolibrary.org/obo/MONDO_0005015
T55 5128-5140 Disease denotes hypertension http://purl.obolibrary.org/obo/MONDO_0005044
T56 5307-5315 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T57 5840-5848 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T58 6063-6071 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T59 7217-7225 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T60 7258-7263 Disease denotes Ebola http://purl.obolibrary.org/obo/MONDO_0005737
T61 7480-7489 Disease denotes influenza http://purl.obolibrary.org/obo/MONDO_0005812
T62 7513-7521 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T63 7513-7517 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T64 7651-7659 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T65 7651-7655 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T66 8096-8100 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T67 8171-8175 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T68 8732-8740 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T69 8732-8736 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T70 8844-8848 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T71 9209-9217 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T72 9209-9213 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T73 9270-9278 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T74 9270-9274 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T75 9489-9497 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T76 9489-9493 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T77 9502-9510 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T78 9502-9506 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T79 9761-9769 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T80 10045-10054 Disease denotes influenza http://purl.obolibrary.org/obo/MONDO_0005812
T81 10557-10565 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T82 11003-11011 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T83 11222-11232 Disease denotes infections http://purl.obolibrary.org/obo/MONDO_0005550
T84 11455-11459 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T85 11501-11509 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T86 12373-12377 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091
T87 12399-12409 Disease denotes infections http://purl.obolibrary.org/obo/MONDO_0005550
T88 12476-12484 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091
T89 12476-12480 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T1 111-112 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T2 151-152 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T3 313-314 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T4 575-576 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T5 637-641 http://purl.obolibrary.org/obo/GO_0005623 denotes cell
T6 900-901 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T7 975-980 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes human
T8 1186-1191 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T9 1306-1309 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T10 1618-1619 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T11 1693-1699 http://purl.obolibrary.org/obo/NCBITaxon_33208 denotes animal
T12 1703-1708 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes human
T13 1758-1763 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes human
T14 1767-1772 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes human
T15 1793-1798 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T16 1999-2001 http://purl.obolibrary.org/obo/CLO_0053733 denotes 11
T17 2020-2032 http://purl.obolibrary.org/obo/OBI_0000245 denotes Organization
T18 2043-2048 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T19 2604-2609 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T20 2640-2641 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T21 2832-2833 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T22 2941-2942 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T23 2968-2969 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T24 3123-3126 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T25 3147-3151 http://purl.obolibrary.org/obo/CLO_0008416 denotes peer
T26 3147-3151 http://purl.obolibrary.org/obo/CLO_0050081 denotes peer
T27 3407-3411 http://purl.obolibrary.org/obo/NCBITaxon_9397 denotes bats
T28 3470-3476 http://purl.obolibrary.org/obo/NCBITaxon_33208 denotes animal
T29 3549-3554 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes human
T30 3555-3559 http://purl.obolibrary.org/obo/UBERON_0002048 denotes lung
T31 3555-3559 http://www.ebi.ac.uk/efo/EFO_0000934 denotes lung
T32 3561-3565 http://purl.obolibrary.org/obo/CLO_0053799 denotes 4, 5
T33 3613-3615 http://purl.obolibrary.org/obo/CLO_0007074 denotes kb
T34 3613-3615 http://purl.obolibrary.org/obo/CLO_0051988 denotes kb
T35 3748-3752 http://purl.obolibrary.org/obo/NCBITaxon_9397 denotes bats
T36 3958-3961 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T37 4164-4169 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T38 4369-4374 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T39 4397-4402 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T40 4575-4576 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T41 4604-4605 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T42 4606-4611 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes human
T43 4841-4842 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T44 5289-5290 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T45 5817-5818 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T46 6146-6151 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T47 6322-6324 http://purl.obolibrary.org/obo/CLO_0053733 denotes 11
T48 6630-6635 http://purl.obolibrary.org/obo/UBERON_0000178 denotes Blood
T49 6630-6635 http://www.ebi.ac.uk/efo/EFO_0000296 denotes Blood
T50 6946-6948 http://purl.obolibrary.org/obo/CLO_0050510 denotes 18
T51 6990-6995 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes Virus
T52 7039-7044 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T53 7064-7065 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T54 7371-7380 http://purl.obolibrary.org/obo/CLO_0000031 denotes cell line
T55 7473-7474 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T56 7534-7536 http://purl.obolibrary.org/obo/CLO_0050507 denotes 22
T57 7558-7561 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T58 7572-7573 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T59 7621-7628 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes viruses
T60 7682-7683 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T61 7709-7714 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T62 7860-7865 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T63 7910-7917 http://purl.obolibrary.org/obo/UBERON_0000473 denotes testing
T64 8090-8095 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T65 8491-8504 http://purl.obolibrary.org/obo/UBERON_0002405 denotes immune system
T66 8524-8527 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T67 8563-8568 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T68 8688-8689 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T69 8719-8720 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T70 8927-8928 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T71 9093-9098 http://purl.obolibrary.org/obo/UBERON_0000178 denotes Blood
T72 9093-9098 http://www.ebi.ac.uk/efo/EFO_0000296 denotes Blood
T73 9107-9110 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T74 9125-9131 http://purl.obolibrary.org/obo/UBERON_0000473 denotes tested
T75 9132-9133 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T76 9352-9357 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes virus
T77 9647-9648 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T78 9821-9822 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T79 10131-10137 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes humans
T80 10231-10237 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes humans
T81 10322-10327 http://purl.obolibrary.org/obo/NCBITaxon_9606 denotes human
T82 10395-10396 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T83 10435-10442 http://purl.obolibrary.org/obo/NCBITaxon_10239 denotes viruses
T84 10664-10671 http://purl.obolibrary.org/obo/UBERON_0000473 denotes testing
T85 10690-10691 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T86 10957-10958 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T87 11381-11382 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T88 11529-11530 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T89 11711-11712 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T90 11766-11767 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T91 11908-11909 http://purl.obolibrary.org/obo/CLO_0001020 denotes A
T92 11910-11913 http://purl.obolibrary.org/obo/NCBITaxon_9596 denotes pan
T93 12458-12459 http://purl.obolibrary.org/obo/CLO_0001020 denotes a

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T1 1214-1221 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T2 1244-1256 Chemical denotes nucleic acid http://purl.obolibrary.org/obo/CHEBI_33696
T3 1252-1256 Chemical denotes acid http://purl.obolibrary.org/obo/CHEBI_37527
T4 3659-3669 Chemical denotes nucleotide http://purl.obolibrary.org/obo/CHEBI_36976
T5 4202-4209 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T6 4470-4473 Chemical denotes TPP http://purl.obolibrary.org/obo/CHEBI_35033|http://purl.obolibrary.org/obo/CHEBI_52279|http://purl.obolibrary.org/obo/CHEBI_9532
T9 4874-4877 Chemical denotes TPP http://purl.obolibrary.org/obo/CHEBI_35033|http://purl.obolibrary.org/obo/CHEBI_52279|http://purl.obolibrary.org/obo/CHEBI_9532
T12 5679-5693 Chemical denotes pharmaceutical http://purl.obolibrary.org/obo/CHEBI_52217
T13 6375-6382 Chemical denotes Protein http://purl.obolibrary.org/obo/CHEBI_16541
T14 6455-6467 Chemical denotes nanoparticle http://purl.obolibrary.org/obo/CHEBI_50803
T15 6532-6539 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T16 6686-6693 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T17 6739-6746 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T18 6789-6793 Chemical denotes acid http://purl.obolibrary.org/obo/CHEBI_37527
T19 6844-6846 Chemical denotes Co http://purl.obolibrary.org/obo/CHEBI_27638
T20 6853-6856 Chemical denotes DNA http://purl.obolibrary.org/obo/CHEBI_16991
T21 7524-7532 Chemical denotes proteins http://purl.obolibrary.org/obo/CHEBI_36080
T22 8247-8254 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T23 8446-8454 Chemical denotes proteins http://purl.obolibrary.org/obo/CHEBI_36080
T24 8574-8587 Chemical denotes nanoparticles http://purl.obolibrary.org/obo/CHEBI_50803
T25 8629-8636 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T26 8745-8752 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T27 8831-8839 Chemical denotes proteins http://purl.obolibrary.org/obo/CHEBI_36080
T28 9220-9227 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T29 9260-9264 Chemical denotes alum http://purl.obolibrary.org/obo/CHEBI_74768
T30 9540-9550 Chemical denotes amino acid http://purl.obolibrary.org/obo/CHEBI_33709
T31 9540-9545 Chemical denotes amino http://purl.obolibrary.org/obo/CHEBI_46882
T32 9546-9550 Chemical denotes acid http://purl.obolibrary.org/obo/CHEBI_37527
T33 9636-9643 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T34 9675-9679 Chemical denotes Acid http://purl.obolibrary.org/obo/CHEBI_37527
T35 9726-9738 Chemical denotes nucleic acid http://purl.obolibrary.org/obo/CHEBI_33696
T36 9734-9738 Chemical denotes acid http://purl.obolibrary.org/obo/CHEBI_37527
T37 9823-9826 Chemical denotes DNA http://purl.obolibrary.org/obo/CHEBI_16991
T38 9960-9963 Chemical denotes DNA http://purl.obolibrary.org/obo/CHEBI_16991
T39 10203-10215 Chemical denotes nucleic acid http://purl.obolibrary.org/obo/CHEBI_33696
T40 10211-10215 Chemical denotes acid http://purl.obolibrary.org/obo/CHEBI_37527
T41 10328-10340 Chemical denotes nucleic acid http://purl.obolibrary.org/obo/CHEBI_33696
T42 10336-10340 Chemical denotes acid http://purl.obolibrary.org/obo/CHEBI_37527
T43 10456-10463 Chemical denotes protein http://purl.obolibrary.org/obo/CHEBI_36080
T44 10478-10491 Chemical denotes nucleic acids http://purl.obolibrary.org/obo/CHEBI_33696
T45 10486-10491 Chemical denotes acids http://purl.obolibrary.org/obo/CHEBI_37527
T46 10646-10652 Chemical denotes formal http://purl.obolibrary.org/obo/CHEBI_48341

LitCovid-PD-GO-BP

Id Subject Object Predicate Lexical cue
T1 2881-2896 http://purl.obolibrary.org/obo/GO_0016032 denotes viral infection
T2 8211-8226 http://purl.obolibrary.org/obo/GO_0006955 denotes immune response
T3 11699-11706 http://purl.obolibrary.org/obo/GO_0051235 denotes storage

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T1 1638-1647 Phenotype denotes pneumonia http://purl.obolibrary.org/obo/HP_0002090
T2 1834-1853 Phenotype denotes respiratory illness http://purl.obolibrary.org/obo/HP_0002086
T3 2261-2280 Phenotype denotes respiratory illness http://purl.obolibrary.org/obo/HP_0002086
T4 2431-2443 Phenotype denotes hypertension http://purl.obolibrary.org/obo/HP_0000822
T5 4778-4790 Phenotype denotes hypertension http://purl.obolibrary.org/obo/HP_0000822
T6 5128-5140 Phenotype denotes hypertension http://purl.obolibrary.org/obo/HP_0000822

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T1 0-44 Sentence denotes The SARS-CoV-2 Vaccine Pipeline: an Overview
T2 46-54 Sentence denotes Abstract
T3 55-72 Sentence denotes Purpose of Review
T4 73-258 Sentence denotes The goal of this review is to provide a timely overview on efforts to develop a vaccine for the 2019 novel coronavirus SARS-CoV-2, the causative agent of coronavirus disease (COVID-19).
T5 260-275 Sentence denotes Recent Findings
T6 276-537 Sentence denotes Previous research efforts to develop a severe acute respiratory syndrome coronavirus (SARS-CoV) vaccine in the years following the 2003 pandemic have opened the door for investigators to design vaccine concepts and approaches for the COVID-19 epidemic in China.
T7 538-656 Sentence denotes Both SARS-CoV and SARS-CoV-2 exhibit a high degree of genetic similarity and bind to the same host cell ACE2 receptor.
T8 657-885 Sentence denotes Based on previous experience with SARS-CoV vaccines, it is expected that all COVID-19 vaccines will require careful safety evaluations for immunopotentiation that could lead to increased infectivity or eosinophilic infiltration.
T9 886-1127 Sentence denotes Besides this, a COVID-19 vaccine target product profile must address vaccinating at-risk human populations including frontline healthcare workers, individuals over the age of 60, and those with underlying and debilitating chronic conditions.
T10 1128-1266 Sentence denotes Among the vaccine technologies under evaluation are whole virus vaccines, recombinant protein subunit vaccines, and nucleic acid vaccines.
T11 1268-1275 Sentence denotes Summary
T12 1276-1348 Sentence denotes Each current vaccine strategy has distinct advantages and disadvantages.
T13 1349-1464 Sentence denotes Therefore, it is paramount that multiple strategies be advanced quickly and then evaluated for safety and efficacy.
T14 1465-1598 Sentence denotes Ultimately, the safety studies to minimize undesired immunopotentiation will become the most significant bottleneck in terms of time.
T15 1600-1743 Sentence denotes In December 2019, a novel coronavirus pneumonia emerged in Wuhan, China, linked initially to animal-to-human transmission in local wet markets.
T16 1744-1910 Sentence denotes Subsequently, human-to-human transmission of the virus commenced, resulting in widespread respiratory illness in Wuhan and other urban areas of Hubei Province, China.
T17 1911-1986 Sentence denotes The coronavirus then spread across China and at least 20 other nations [1].
T18 1987-2129 Sentence denotes On February 11, the World Health Organization named the virus SARS-CoV-2 and the syndrome was named COVID-19, or coronavirus disease 2019 [2].
T19 2130-2448 Sentence denotes Although not as lethal as the severe acute respiratory syndrome (SARS) outbreak in 2003, COVID-19 is still characterized by severe respiratory illness and significant mortality, especially among individuals over the age of 60 years and in those with underlying chronic conditions such as diabetes and hypertension [1].
T20 2449-2681 Sentence denotes Moreover, SARS-CoV-2 is highly transmissible with an estimated reproductive number (R0) of 2.2, i.e., one infected individual is estimated to transmit the virus to 2.2 other individuals, and a mean incubation period of 5.8 days [1].
T21 2682-2951 Sentence denotes The finding that SARS-CoV-2 is transmitted from infected individuals without symptoms [3], together with its ability to cause pandemic disease within a period of weeks, suggests that control of this viral infection will be challenging without the prospect of a vaccine.
T22 2952-3071 Sentence denotes Here we provide a brief overview of some of the major candidates and the challenges of implementing vaccine strategies.
T23 3072-3295 Sentence denotes Since much of the information about these vaccines has not yet entered the peer-reviewed literature, for this brief overview, we rely significantly on the information made publicly available on websites and other documents.
T24 3297-3332 Sentence denotes COVID-19 and Target Product Profile
T25 3333-3485 Sentence denotes Like the SARS coronavirus, SARS-CoV-2 is believed to have originated from bats before infecting one or more mammal species sold in Wuhan animal markets.
T26 3486-3620 Sentence denotes Both coronaviruses bind to similar ACE2 receptors found in the human lung [4, 5], and both exhibit genomes of approximately 30 kb [6].
T27 3621-3757 Sentence denotes SARS-CoV-2 exhibits approximately 89% nucleotide similarly to SARS-like coronaviruses (genus Betacoronavirus) found in Chinese bats [6].
T28 3758-3878 Sentence denotes On this basis, the early shaping of potential SARS-CoV-2 vaccine strategies built on those advanced previously for SARS.
T29 3879-4223 Sentence denotes One of the major hurdles in the early development of SARS coronavirus vaccines has been the finding of undesired immunopotentiation in the form of eosinophilic infiltration or increased infectivity, which is noted to occur following challenge infections after immunizations with whole virus vaccines or even complete spike protein vaccines [7].
T30 4224-4422 Sentence denotes The basis of this finding is still under investigation, but it was not considered surprising given that this phenomenon also occurred with whole virus respiratory syncytial virus (RSV) vaccines [7].
T31 4423-4552 Sentence denotes Therefore, any vaccine target product profile (TPP) must give full safety considerations to avoid the immunopotentiation (Box 1).
T32 4553-4628 Sentence denotes Box 1 Key features of a target product profile for a human COVID-19 vaccine
T33 4629-4669 Sentence denotes • Minimizes undesired immunopotentiation
T34 4670-4709 Sentence denotes • Suitable for adult healthcare workers
T35 4710-4790 Sentence denotes • Suitable for adults > 60 years old or with underlying diabetes or hypertension
T36 4791-4817 Sentence denotes • Suitable for stockpiling
T37 4818-4912 Sentence denotes Another key element of a SARS-CoV or SARS-CoV-2 vaccine TPP is the intended target population.
T38 4913-5145 Sentence denotes Currently, those at the highest risk of acquiring COVID-19 or suffering significant health deterioration are frontline healthcare workers, individuals over the age of 60 years, or those with underlying diabetes and hypertension [8].
T39 5146-5236 Sentence denotes Therefore, such populations might be prioritized for vaccine clinical trials or licensure.
T40 5237-5383 Sentence denotes Still, another feature is the real possibility that a new vaccine for COVID-19 may not be available in time for this current epidemic or pandemic.
T41 5384-5449 Sentence denotes Therefore, it should be made available for potential stockpiling.
T42 5450-5625 Sentence denotes Along those lines, vaccines developed and produced for global health security or biodefense are often considered less profitable than traditional childhood and adult vaccines.
T43 5626-5780 Sentence denotes For that reason, very few of the major multinational pharmaceutical companies appear to have expressed upfront commercial interest in entering this space.
T44 5782-5796 Sentence denotes The Strategies
T45 5797-5876 Sentence denotes Shown in Table 1 is a summary of the major COVID-19 vaccines under development.
T46 5877-6048 Sentence denotes This list is not exhaustive but instead reflects some of the major vaccines highlighted in company materials or publicly available documents, including biocentury.com [9].
T47 6049-6100 Sentence denotes Table 1 Major COVID-19 vaccine development programs
T48 6101-6139 Sentence denotes Consortium Candidate vaccine Reference
T49 6140-6160 Sentence denotes Whole virus vaccines
T50 6161-6259 Sentence denotes   Janssen (Johnson & Johnson) Adenovirus-vectored vaccine using AdVac® and PER.C6® technology [10]
T51 6260-6325 Sentence denotes   Codagenix/Serum Institute of India Live-attenuated vaccine [11]
T52 6326-6342 Sentence denotes Subunit vaccines
T53 6343-6432 Sentence denotes   University of Queensland/CEPI Protein-based vaccine using Molecular Clamp platform [12]
T54 6433-6483 Sentence denotes   Novavax Recombinant nanoparticle technology [13]
T55 6484-6572 Sentence denotes   Clover Bipharmaceuticals S-trimer recombinant protein using Trimer-Tag technology [14]
T56 6573-6712 Sentence denotes   Baylor College of Medicine, Fudan University, New York Blood Center, Univ Texas Medical Branch Coronavirus RBD protein-based vaccine [15]
T57 6713-6780 Sentence denotes   Vaxart Oral recombinant protein vaccine using VAAST platform [16]
T58 6781-6802 Sentence denotes Nucleic acid vaccines
T59 6803-6912 Sentence denotes   Inovio/Beijing Advaccine Biotechnology Co./CEPI DNA vaccine (INO-4800, based on INO-4700 MERS vaccine) [17]
T60 6913-6949 Sentence denotes   Moderna/NIH/CEPI mRNA vaccine [18]
T61 6950-6982 Sentence denotes   CureVac/CEPI mRNA vaccine [19]
T62 6984-7004 Sentence denotes Whole Virus Vaccines
T63 7005-7106 Sentence denotes Live-attenuated or inactive whole virus vaccines represent a classic strategy for viral vaccinations.
T64 7107-7401 Sentence denotes According to an industry newsletter, Johnson & Johnson is one of the few multinational companies embarking on COVID-19 vaccines [20]; similar to their Ebola vaccine platform, they are employing Janssen’s AdVac® adenoviral vector and manufacturing in their PER.C6® cell line technology [20, 21].
T65 7402-7538 Sentence denotes In addition, researchers at the University of Hong Kong have developed a live influenza vaccine that expresses SARS-CoV-2 proteins [22].
T66 7539-7681 Sentence denotes Finally, Codagenix has developed a “codon deoptimization” technology to attenuate viruses [23] and is exploring SARS-CoV-2 vaccine strategies.
T67 7682-7845 Sentence denotes A major advantage of whole virus vaccines is their inherent immunogenicity and ability to stimulate toll-like receptors (TLRs) including TLR 3, TLR 7/8, and TLR 9.
T68 7846-7942 Sentence denotes However, live virus vaccines often require extensive additional testing to confirm their safety.
T69 7943-8126 Sentence denotes This is especially an issue for coronavirus vaccines, given the findings of increased infectivity following immunization with live or killed whole virus SARS coronavirus vaccines [7].
T70 8128-8144 Sentence denotes Subunit Vaccines
T71 8145-8310 Sentence denotes Subunit vaccines for both SARS coronaviruses rely on eliciting an immune response against the S-spike protein to prevent its docking with the host ACE2 receptor [7].
T72 8311-8505 Sentence denotes Already, under funding from the Coalition for Epidemic Preparedness (CEPI), the University of Queensland is synthesizing viral surface proteins, to present them more easily to the immune system.
T73 8506-8913 Sentence denotes Moreover, Novavax has developed and produced immunogenic virus-like nanoparticles based on recombinant expression of the S-protein [24] while Clover Biopharmaceuticals is developing a subunit vaccine consisted of a trimerized SARS-CoV-2 S-protein using their patented Trimer-Tag® technology [14], although some full-length S-proteins for SARS also elicit increased infectivity and eosinophilic infiltration.
T74 8914-9240 Sentence denotes Accordingly, a consortium led by Texas Children’s Hospital Center for Vaccine Development at Baylor College of Medicine (including University of Texas Medical Branch and New York Blood Center) has developed and tested a subunit vaccine comprised of only the receptor-binding domain (RBD) of the SARS-CoV S-protein [7, 25, 26].
T75 9241-9368 Sentence denotes When formulated on alum, the SARS-CoV RBD vaccine elicits high levels of protective immunity on the homologous virus challenge.
T76 9369-9462 Sentence denotes An advantage of the RBD-based vaccine is its ability to minimize host immunopotentiation [7].
T77 9463-9665 Sentence denotes Initial findings that the SARS-CoV and SARS-CoV-2 RBDs exhibit more than 80% amino acid similarity and bind to the same ACE2 receptor offer an opportunity to develop either protein as a subunit vaccine.
T78 9667-9688 Sentence denotes Nucleic Acid Vaccines
T79 9689-9770 Sentence denotes Several major biotechs have advanced nucleic acid vaccine platforms for COVID-19.
T80 9771-9928 Sentence denotes For example, Inovio Pharmaceuticals is developing a DNA vaccine, while others, such as Moderna Therapeutics and Curevac, are exploring RNA vaccine platforms.
T81 9929-10138 Sentence denotes The concept of immunizing with DNA began with promising results in mice in 1993 showing protective immunity against influenza, but for decades, these findings have not translated to similar findings in humans.
T82 10139-10349 Sentence denotes More recently, new modifications and formulations have improved nucleic acid performance in humans, with an expectation that this approach might eventually lead to the first licensed human nucleic acid vaccine.
T83 10351-10371 Sentence denotes Concluding Statement
T84 10372-10566 Sentence denotes There are now at least a half-dozen candidates, including live viruses, recombinant protein subunits, and nucleic acids that may ultimately offer promise as preventive vaccines against COVID-19.
T85 10567-10926 Sentence denotes However, each of these vaccines may require additional manufacturing steps and formal toxicology testing before submitting a regulatory package to national regulatory agencies and be able to commence the clinical development, first with phase 1 clinical trials for safety and immunogenicity, and later, phase 2 and phase 3 trials for both safety and efficacy.
T86 10927-11233 Sentence denotes The next few months represent a critical period for determining whether the COVID-19 epidemic in Wuhan and Central China will spread across Asia and globally, or whether the warmer months of spring and summer in the Northern Hemisphere will reduce transmission of typically seasonal coronavirus infections.
T87 11234-11297 Sentence denotes In the former situation, we will urgently require new vaccines.
T88 11298-11329 Sentence denotes However, the challenge remains.
T89 11330-11510 Sentence denotes Moving forward, we must recognize that we have had a new major coronavirus epidemic every decade in the twenty-first century—SARS in the 2000s, MERS in the 2010s, and now COVID-19.
T90 11511-11707 Sentence denotes It is, therefore, a global security priority to advance and stockpile coronavirus vaccines, and to identify international funding mechanisms to support their development, manufacture, and storage.
T91 11708-11907 Sentence denotes As a matter of fact, this recent outbreak should serve as a beacon to call upon the international research community to not only react but also prepare for the next coronavirus crossing into mammals.
T92 11908-12044 Sentence denotes A pan-coronavirus vaccine is urgently needed and appears scientifically feasible if sufficient resources are made available in due time.
T93 12046-12127 Sentence denotes This article is part of the Topical Collection on Hot Topics in Tropical Medicine
T94 12128-12144 Sentence denotes Publisher’s Note
T95 12145-12263 Sentence denotes Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
T96 12265-12298 Sentence denotes Compliance with Ethical Standards
T97 12300-12320 Sentence denotes Conflict of Interest
T98 12321-12410 Sentence denotes The authors have developed subunit vaccines against SARS and MERS coronavirus infections.
T99 12411-12487 Sentence denotes They are involved in the process of developing a vaccine against SARS-CoV-2.

2_test

Id Subject Object Predicate Lexical cue
32219057-23252385-24561033 4220-4221 23252385 denotes 7
32219057-23252385-24561034 4419-4420 23252385 denotes 7
32219057-23252385-24561035 8123-8124 23252385 denotes 7
32219057-23252385-24561036 8307-8308 23252385 denotes 7
32219057-24736006-24561037 8638-8640 24736006 denotes 24
32219057-23252385-24561038 9229-9230 23252385 denotes 7
32219057-28456726-24561039 9232-9234 28456726 denotes 25
32219057-23252385-24561040 9459-9460 23252385 denotes 7

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
1 4-14 Species denotes SARS-CoV-2 Tax:2697049
6 169-191 Species denotes 2019 novel coronavirus Tax:2697049
7 192-202 Species denotes SARS-CoV-2 Tax:2697049
8 227-246 Disease denotes coronavirus disease MESH:D018352
9 248-256 Disease denotes COVID-19 MESH:C000657245
21 642-646 Gene denotes ACE2 Gene:59272
22 315-360 Species denotes severe acute respiratory syndrome coronavirus Tax:694009
23 362-370 Species denotes SARS-CoV Tax:694009
24 543-551 Species denotes SARS-CoV Tax:694009
25 556-566 Species denotes SARS-CoV-2 Tax:2697049
26 691-699 Species denotes SARS-CoV Tax:694009
27 975-980 Species denotes human Tax:9606
28 1202-1213 Species denotes recombinant Tax:575864
29 510-518 Disease denotes COVID-19 MESH:C000657245
30 734-742 Disease denotes COVID-19 MESH:C000657245
31 902-910 Disease denotes COVID-19 MESH:C000657245
52 1703-1708 Species denotes human Tax:9606
53 1758-1763 Species denotes human Tax:9606
54 1767-1772 Species denotes human Tax:9606
55 1915-1926 Species denotes coronavirus Tax:11118
56 2049-2059 Species denotes SARS-CoV-2 Tax:2697049
57 2459-2469 Species denotes SARS-CoV-2 Tax:2697049
58 2699-2709 Species denotes SARS-CoV-2 Tax:2697049
59 1620-1647 Disease denotes novel coronavirus pneumonia MESH:C000657245
60 1834-1853 Disease denotes respiratory illness MESH:D012140
61 2087-2095 Disease denotes COVID-19 MESH:C000657245
62 2100-2124 Disease denotes coronavirus disease 2019 MESH:C000657245
63 2160-2193 Disease denotes severe acute respiratory syndrome MESH:D045169
64 2219-2227 Disease denotes COVID-19 MESH:C000657245
65 2261-2280 Disease denotes respiratory illness MESH:D012140
66 2297-2306 Disease denotes mortality MESH:D003643
67 2418-2426 Disease denotes diabetes MESH:D003920
68 2431-2443 Disease denotes hypertension MESH:D006973
69 2555-2563 Disease denotes infected MESH:D007239
70 2730-2738 Disease denotes infected MESH:D007239
71 2887-2896 Disease denotes infection MESH:D007239
73 3297-3305 Disease denotes COVID-19 MESH:C000657245
84 3521-3525 Gene denotes ACE2 Gene:59272
85 3342-3358 Species denotes SARS coronavirus Tax:694009
86 3360-3370 Species denotes SARS-CoV-2 Tax:2697049
87 3441-3447 Species denotes mammal Tax:9606
88 3491-3504 Species denotes coronaviruses Tax:11118
89 3549-3554 Species denotes human Tax:9606
90 3621-3631 Species denotes SARS-CoV-2 Tax:2697049
91 3693-3706 Species denotes coronaviruses Tax:11118
92 3714-3729 Species denotes Betacoronavirus Tax:694002
93 3804-3814 Species denotes SARS-CoV-2 Tax:2697049
96 4766-4774 Disease denotes diabetes MESH:D003920
97 4778-4790 Disease denotes hypertension MESH:D006973
100 4606-4611 Species denotes human Tax:9606
101 4612-4620 Disease denotes COVID-19 MESH:C000657245
106 3932-3948 Species denotes SARS coronavirus Tax:694009
107 4375-4402 Species denotes respiratory syncytial virus Tax:12814
108 4404-4407 Species denotes RSV Tax:12814
109 4122-4132 Disease denotes infections MESH:D007239
117 4843-4851 Species denotes SARS-CoV Tax:694009
118 4855-4865 Species denotes SARS-CoV-2 Tax:2697049
119 4874-4877 Chemical denotes TPP
120 4963-4971 Disease denotes COVID-19 MESH:C000657245
121 5115-5123 Disease denotes diabetes MESH:D003920
122 5128-5140 Disease denotes hypertension MESH:D006973
123 5307-5315 Disease denotes COVID-19 MESH:C000657245
133 6191-6201 Species denotes Adenovirus Tax:10508
134 6670-6681 Species denotes Coronavirus Tax:11118
135 6443-6454 Species denotes Recombinant Tax:575864
136 6520-6531 Species denotes recombinant Tax:575864
137 6727-6738 Species denotes recombinant Tax:575864
138 6172-6179 Disease denotes Johnson MESH:C535882
139 6182-6189 Disease denotes Johnson MESH:C535882
140 6894-6898 Disease denotes MERS MESH:D018352
141 6240-6242 CellLine denotes C6 CVCL:X905
143 6063-6071 Disease denotes COVID-19 MESH:C000657245
145 5840-5848 Disease denotes COVID-19 MESH:C000657245
158 7782-7801 Gene denotes toll-like receptors
159 7819-7824 Gene denotes TLR 3 Gene:7098
160 7839-7844 Gene denotes TLR 9 Gene:54106
161 7258-7263 Species denotes Ebola Tax:1570291
162 7513-7523 Species denotes SARS-CoV-2 Tax:2697049
163 7651-7661 Species denotes SARS-CoV-2 Tax:2697049
164 7975-7986 Species denotes coronavirus Tax:11118
165 8096-8112 Species denotes SARS coronavirus Tax:694009
166 7144-7151 Disease denotes Johnson MESH:C535882
167 7154-7161 Disease denotes Johnson MESH:C535882
168 7217-7225 Disease denotes COVID-19 MESH:C000657245
169 7367-7369 CellLine denotes C6 CVCL:X905
184 8292-8296 Gene denotes ACE2 Gene:59272
185 8627-8636 Gene denotes S-protein Gene:43740568
186 9583-9587 Gene denotes ACE2 Gene:59272
187 9218-9227 Gene denotes S-protein Gene:43740568
188 8743-8752 Gene denotes S-protein Gene:43740568
189 8171-8189 Species denotes SARS coronaviruses Tax:694009
190 8732-8742 Species denotes SARS-CoV-2 Tax:2697049
191 8953-8961 Species denotes Children Tax:9606
192 9209-9217 Species denotes SARS-CoV Tax:694009
193 9270-9278 Species denotes SARS-CoV Tax:694009
194 9489-9497 Species denotes SARS-CoV Tax:694009
195 9502-9512 Species denotes SARS-CoV-2 Tax:2697049
196 8597-8608 Species denotes recombinant Tax:575864
197 9260-9264 Chemical denotes alum MESH:C041524
203 9996-10000 Species denotes mice Tax:10090
204 10131-10137 Species denotes humans Tax:9606
205 10231-10237 Species denotes humans Tax:9606
206 10322-10327 Species denotes human Tax:9606
207 9761-9769 Disease denotes COVID-19 MESH:C000657245
218 11393-11404 Species denotes coronavirus Tax:11118
219 11581-11592 Species denotes coronavirus Tax:11118
220 11873-11884 Species denotes coronavirus Tax:11118
221 11914-11925 Species denotes coronavirus Tax:11118
222 10444-10455 Species denotes recombinant Tax:575864
223 10557-10565 Disease denotes COVID-19 MESH:C000657245
224 11003-11011 Disease denotes COVID-19 MESH:C000657245
225 11201-11232 Disease denotes seasonal coronavirus infections MESH:D018352
226 11474-11478 Disease denotes MERS MESH:D018352
227 11501-11509 Disease denotes COVID-19 MESH:C000657245
230 12476-12486 Species denotes SARS-CoV-2 Tax:2697049
231 12382-12409 Disease denotes MERS coronavirus infections MESH:D018352